炎症
内科学
代谢综合征
脂肪变性
全身炎症
肝病
胃肠病学
促炎细胞因子
糖尿病
作者
N Gehrke,Jörn M. Schattenberg
标识
DOI:10.1053/j.gastro.2020.02.020
摘要
Nonalcoholic fatty liver disease (NAFLD) is a global and growing health concern. Emerging evidence points toward metabolic inflammation as a key process in the fatty liver that contributes to multiorgan morbidity. Key extrahepatic comorbidities that are influenced by NAFLD are type 2 diabetes, cardiovascular disease, and impaired neurocognitive function. Importantly, the presence of nonalcoholic steatohepatitis and advanced hepatic fibrosis increase the risk for systemic comorbidity in NAFLD. Although the precise nature of the crosstalk between the liver and other organs has not yet been fully elucidated, there is emerging evidence that metabolic inflammation—in part, emanating from the fatty liver—is the engine that drives cellular dysfunction, cell death, and deleterious remodeling within various body tissues. This review describes several inflammatory pathways and mediators that have been implicated as links between NAFLD and type 2 diabetes, cardiovascular disease, and neurocognitive decline.
科研通智能强力驱动
Strongly Powered by AbleSci AI